UY36636A - Compuesto derivado de butanamida con actividad antiparasitaria - Google Patents

Compuesto derivado de butanamida con actividad antiparasitaria

Info

Publication number
UY36636A
UY36636A UY0001036636A UY36636A UY36636A UY 36636 A UY36636 A UY 36636A UY 0001036636 A UY0001036636 A UY 0001036636A UY 36636 A UY36636 A UY 36636A UY 36636 A UY36636 A UY 36636A
Authority
UY
Uruguay
Prior art keywords
activity
antiparasitary
butanamide
composite derived
composite
Prior art date
Application number
UY0001036636A
Other languages
English (en)
Inventor
David Matthew Wilson
Original Assignee
Glaxosmithkline Ip Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev Ltd filed Critical Glaxosmithkline Ip Dev Ltd
Publication of UY36636A publication Critical patent/UY36636A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a un compuesto de fórmula (I) que tiene actividad farmacológica, a procesos para su preparación, a composiciones farmacéuticas y a su uso para el tratamiento de ciertas infecciones protozoarias parasitarias,tales como la malaria, en particular, la infección por Plasmodium falciparum.
UY0001036636A 2015-04-21 2016-04-19 Compuesto derivado de butanamida con actividad antiparasitaria UY36636A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15382200 2015-04-21

Publications (1)

Publication Number Publication Date
UY36636A true UY36636A (es) 2016-11-30

Family

ID=53005539

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036636A UY36636A (es) 2015-04-21 2016-04-19 Compuesto derivado de butanamida con actividad antiparasitaria

Country Status (5)

Country Link
US (1) US9624219B2 (es)
AR (1) AR104315A1 (es)
TW (1) TW201702242A (es)
UY (1) UY36636A (es)
WO (1) WO2016169906A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8431608B2 (en) * 2007-08-17 2013-04-30 Icagen Inc. Heterocycles as potassium channel modulators
WO2011061277A1 (en) * 2009-11-20 2011-05-26 Glaxo Group Limited Amino aryl acetamides and their use in the treatment of malaria
GB201410407D0 (en) 2014-06-11 2014-07-23 Univ Dundee And Syngene Internat Ltd Plc And Consejo Superior De Investigaciones Cientificas And Med Treatment of chagas disease
MA41140A (fr) 2014-12-12 2017-10-17 Cancer Research Tech Ltd Dérivés de 2,4-dioxo-quinazoline-6-sulfonamide en tant qu'inhibiteurs de la parg
MA41898A (fr) 2015-04-10 2018-02-13 Hoffmann La Roche Dérivés de quinazolinone bicyclique

Also Published As

Publication number Publication date
WO2016169906A1 (en) 2016-10-27
AR104315A1 (es) 2017-07-12
US20160311821A1 (en) 2016-10-27
TW201702242A (zh) 2017-01-16
US9624219B2 (en) 2017-04-18

Similar Documents

Publication Publication Date Title
ECSP18048718A (es) Imidazolilimidazoles condensados como compuestos antivirales
NI201400083A (es) Compuesto de imidazopirrolidinona
DOP2016000094A (es) Compuestos derivados de piridilo bicíclicos fusionados a anillo como inhibidores de fgfr4.
CR20150370A (es) Compuestos antivirales
MX2020012132A (es) Compuestos de azapiridona y usos de los mismos.
ECSP11011517A (es) Compuestos antivirales
GT201200004A (es) Imidazoles fusionados y composiciones que los contienen para el tratamiento de enfermedades parasitarias, como por ejemplo malaria
UY35263A (es) Compuestos terapéuticos
NI201400032A (es) Piridopirazinas anticancerígenas via la
CU20190101A7 (es) Imidazopirimidinas diazabicíclicas sustituidas
UY33735A (es) Compuestos antivirales
CU20160020A7 (es) Derivados de imidazoquinolinas sustituidas inhibidores de mek para el tratamiento del cáncer
EA201790571A1 (ru) Пирролопиримидины для применения при инфекции, вызванной вирусом гриппа
MX2015012833A (es) Composiciones antibioticas de ceftolozano.
GT201500247A (es) Imidazopiridazinas sustituidas
BR112017005231A2 (pt) formulações eutéticas de cloridrato de ciclobenzaprina
UY37193A (es) Nuevos compuestos antivíricos
BR112017009289A2 (pt) métodos de administrar composições de amantadina
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
CO6321288A2 (es) Sales de compuestos inhibidores de vih
MX2021012440A (es) Farmacos precursores de oxabicicloheptanos.
LT2939665T (lt) Farmacinė kompozicija, skirta živ infekcijų gydymui
BR112016028083A2 (pt) Composição oral farmacêutica de isotretinoina e seu processo de preparação
CL2015001502A1 (es) Composición farmacéutica que comprende desloratadina y prendnisolona y uso de la misma.
CO2017005759A2 (es) Composiciones farmacéuticas de acción prolongada para la hepatitis c